GET(T)ING(E) BEYOND THE SHORT-TERM TROUBLES (BUY; 51% UPSIDE)
17/06/22 -" Getinge’s (Buy, Sweden) journey on the bourses has been a story of two extremes since we zeroed in on it in January 2021. While the stock rode the multiple earnings surprises to all-time highs ..."
Pages
59
Language
English
Published on
17/06/22
You may also be interested by these reports :
15/01/26
In late-2024, when we last teased the story of DiaSorin (BUY; Italy), a family-owned in-vitro diagnostic company specialising in immunodiagnostics ...
07/01/26
Yesterday, Meta announced a delay in the international rollout of the Ray-Ban display smart glasses. The market reacted positively to this news, on ...
30/12/25
Despite revising our estimates and target price downward, DiaSorin remains a compelling investment opportunity. This is underpinned by strong ...
15/12/25
We have revised our estimates upwards to account for enhanced profitability, despite the effects of tariffs and foreign exchange headwinds. This ...